Role of IL-6 in Angiotensin II-induced Retinal Vascular Inflammation

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2009 Oct 17

PMID 19834028

Citations 48

Authors

Modesto Rojas

Wenbo Zhang

Dexter L Lee

Maritza J Romero

Doan T Nguyen

Mohamed Al-Shabrawey

Nai-Tse Tsai

Gregory I Liou

Michael W Brands

Robert W Caldwell

Ruth B Caldwell

Affiliations

Soon will be listed here.

Abstract

Purpose: The production of proinflammatory cytokines has been shown to play a critical role in a variety of retinal vascular diseases. Angiotensin II and VEGF have been implicated in the initiation of vascular inflammation and retinal vascular disease. However, detailed mechanisms of this process and interactions between inflammatory agonists and angiotensin II in promoting retinopathy are poorly understood. The present study was an investigation of the role of interleukin (IL)-6 in angiotensin II-induced retinopathy.

Methods: Rats and IL-6-deficient and wild-type mice were treated with angiotensin II or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localization of VEGF or IL-6. Leukocyte adhesion was assayed by concanavalin A labeling. Vascular density was determined by morphometric analysis. NADPH oxidase activity was assayed by dihydroethidium imaging of superoxide.

Results: Intravitreal injection of angiotensin II caused increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels. IL-6 protein was localized to CD11b-positive microglia and macrophage-like cells. Angiotensin II treatment stimulated increases in retinal levels of VEGF expression and NADPH oxidase activity, which were associated with increased surface area and remodeling of the retinal vessels. These effects were blocked by knocking out IL-6. Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient mice.

Conclusions: The results indicate that IL-6 expression is essential for angiotensin II-induced increases in retinal VEGF expression, leukostasis, and vascular remodeling. The data suggest a critical role for IL-6 in mediating angiotensin II-induced retinal vascular inflammation and remodeling.

Citing Articles

Enhancing Inflammatory Factors, Nitric Oxide, and Arterial Stiffness Through Aquatic Walking for Amelioration and Disease Prevention: Targeting in Obese Elderly Women.

Son W, Jeong W, Park I, Ha M Mediators Inflamm. 2025; 2024:5520987.

PMID: 39742290 PMC: 11685319. DOI: 10.1155/mi/5520987.

Acute Hemorrhagic Leukoencephalitis with Concurrent Retinal Vasculitis in an Elderly Japanese Patient.

Yamaguchi Y, Sawaya R, Shichinohe N, Tanei Z, Yamasaki M, Tomeoka F Intern Med. 2024; 64(2):301-306.

PMID: 38897959 PMC: 11802224. DOI: 10.2169/internalmedicine.3518-24.

Diabetic Müller-Glial-Cell-Specific Il6ra Knockout Mice Exhibit Accelerated Retinal Functional Decline and Thinning of the Inner Nuclear Layer.

Glass J, Robinson R, Greenway G, Jones G, Sharma S Invest Ophthalmol Vis Sci. 2023; 64(15):1.

PMID: 38038619 PMC: 10697173. DOI: 10.1167/iovs.64.15.1.

Blockade of interleukin-6 trans-signaling prevents mitochondrial dysfunction and cellular senescence in retinal endothelial cells.

Hoffman J, Robinson R, Greenway G, Glass J, Budkin S, Sharma S Exp Eye Res. 2023; 237:109721.

PMID: 37956941 PMC: 10759313. DOI: 10.1016/j.exer.2023.109721.

Early detection and correlation of tear fluid inflammatory factors that influence angiogenesis in premature infants with and without retinopathy of prematurity.

Vinekar A, Nair A, Sinha S, Vaidya T, Shetty R, Ghosh A Indian J Ophthalmol. 2023; 71(11):3465-3472.

PMID: 37870008 PMC: 10752326. DOI: 10.4103/IJO.IJO_3407_22.

References

Ellis E, Guberski D, Grant M . Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med. 2000; 28(1):91-101. DOI: 10.1016/s0891-5849(99)00216-6. View

Schrader L, Kinzenbaw D, Johnson A, Faraci F, Didion S . IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol. 2007; 27(12):2576-81. DOI: 10.1161/ATVBAHA.107.153080. View

Downie L, Pianta M, Vingrys A, Wilkinson-Berka J, Fletcher E . AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia. 2008; 56(10):1076-90. DOI: 10.1002/glia.20680. View

Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T . Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol. 2007; 170(6):2149-58. PMC: 1899441. DOI: 10.2353/ajpath.2007.061018. View

Yan S, Tritto I, Pinsky D, Liao H, Huang J, Fuller G . Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem. 1995; 270(19):11463-71. DOI: 10.1074/jbc.270.19.11463. View

Wei L, Kuo M, Chen C, Chou C, Lai K, Lee C . Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 2003; 22(10):1517-27. DOI: 10.1038/sj.onc.1206226. View

Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y . Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46(8):2925-31. DOI: 10.1167/iovs.04-1476. View

Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S . Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002; 133(1):70-7. DOI: 10.1016/s0002-9394(01)01269-7. View

Chen P, Guo A, Edwards P, Trick G, Scicli A . Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. Am J Physiol Regul Integr Comp Physiol. 2007; 293(4):R1619-29. DOI: 10.1152/ajpregu.00290.2007. View

10.

Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H . Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2005; 244(3):309-15. DOI: 10.1007/s00417-004-1087-4. View

11.

Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K . Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2004; 243(1):3-8. DOI: 10.1007/s00417-004-0950-7. View

12.

Stolk J, Hiltermann T, Dijkman J, Verhoeven A . Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994; 11(1):95-102. DOI: 10.1165/ajrcmb.11.1.8018341. View

13.

Gustavsson C, Agardh C, Hagert P, Agardh E . Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina. 2008; 28(4):645-52. DOI: 10.1097/IAE.0b013e31815ec32d. View

14.

Tolentino M, McLeod D, Taomoto M, Otsuji T, Adamis A, Lutty G . Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol. 2002; 133(3):373-85. DOI: 10.1016/s0002-9394(01)01381-2. View

15.

Adamis A, Berman A . Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008; 30(2):65-84. DOI: 10.1007/s00281-008-0111-x. View

16.

Ferrara N . VEGF as a therapeutic target in cancer. Oncology. 2005; 69 Suppl 3:11-6. DOI: 10.1159/000088479. View

17.

Gilbert R, Kelly D, Cox A, Wilkinson-Berka J, Rumble J, Osicka T . Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia. 2000; 43(11):1360-7. DOI: 10.1007/s001250051539. View

18.

Sappington R, Sidorova T, Long D, Calkins D . TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest Ophthalmol Vis Sci. 2008; 50(2):717-28. PMC: 3549616. DOI: 10.1167/iovs.08-2321. View

19.

Recinos 3rd A, LeJeune W, Sun H, Lee C, Tieu B, Lu M . Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis. 2006; 194(1):125-33. PMC: 2196437. DOI: 10.1016/j.atherosclerosis.2006.10.013. View

20.

Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H . Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006; 47(6):2686-92. DOI: 10.1167/iovs.05-1458. View